News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

December

10

National Experts in Autoimmunity Tapped to Serve on Exagen’s Scientific Advisory Board

Members include Dr. Arthur Weinstein, Dr. Joel Kremer, Dr. Anca Askanase, Dr. Andrew Concoff, Dr. Maureen McMahon, and Dr. Vasileios...

12

Exagen Inc. Reports Third Quarter 2019 Results

AVISE® Testing Revenue Drives 27% Revenue Growth SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:...

21

Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America

CEO Ron Rocca Will Be Recognized at LFA Annual Evening of Hope Gala in...

15

Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing

First ever prospective randomized multicenter clinical utility study shows the favorable impact of AVISE®...

19

Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research

Focus on the development of more effective tools to diagnose, prognose and monitor these...

Recent developments